Structure Therapeutics
GPCR
84 hedge funds and large institutions have $1.64B invested in Structure Therapeutics in 2023 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 29 increasing their positions, 6 reducing their positions, and 6 closing their positions.
871% more capital inflows, than outflows
Capital inflows: $542M | Capital outflows: $55.9M
600% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 6
383% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 6
175% more funds holding in top 10
Funds holding in top 10: 4 → 11 (+7)
75% more funds holding
Funds holding: 48 → 84 (+36)
27.96% more ownership
Funds ownership: 46.12% → 74.08% (+28%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$64.9M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$51.8M |
| 3 |
Driehaus Capital Management
Chicago,
Illinois
|
+$40.4M |
| 4 |
TCG Crossover Management
Palo Alto,
California
|
+$37.1M |
| 5 |
HSG Holding
Na,
Hong Kong
|
+$34.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Monashee Investment Management
Boston,
Massachusetts
|
-$23.8M |
| 2 |
Deep Track Capital
Greenwich,
Connecticut
|
-$23.6M |
| 3 |
Octagon Capital Advisors
New York
|
-$3.12M |
| 4 |
Nantahala Capital Management
New Canaan,
Connecticut
|
-$2.08M |
| 5 |
Renaissance Technologies
New York
|
-$1.37M |
GPCR Hedge Fund Activity: Q3 2023 in Review
84 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in Structure Therapeutics (GPCR) for Q3 2023, worth a combined $1.64B — up 135% from $699M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new GPCR positions and 6 closed out — a net gain of 36 holders — while 29 added to existing stakes and 6 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $64.9M. The largest seller was Monashee Investment Management, cutting an estimated $23.8M.
- 84 institutional investors held Structure Therapeutics (GPCR) as of Q3 2023, up from 48 in Q2 2023.
- Funds reported $1.64B of Structure Therapeutics stock for Q3 2023, up 135% quarter-over-quarter.
- 42 funds opened new Structure Therapeutics positions in Q3 2023 and 6 closed out, a net change of +36 holders.
- The largest Structure Therapeutics buyer in Q3 2023 was Janus Henderson Group, an estimated $64.9M added.
- The largest Structure Therapeutics seller in Q3 2023 was Monashee Investment Management, an estimated $23.8M sold.
Based on aggregated 13F filings for Q3 2023.